Cargando…

A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms

Background: Infantile spasms is a rare disease characterized by distinct seizures and hypsarrhythmia. Adrenocorticotropic hormone (ACTH) is available as a natural product (repository corticotropin injection, [RCI]; Acthar® Gel) and as synthetic analogs. RCI is a naturally-sourced complex mixture of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Duchowny, Michael S., Chopra, Ishveen, Niewoehner, John, Wan, George J., Devine, Beth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Columbia Data Analytics, LLC 2021
Materias:	Neurological Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839629/ https://www.ncbi.nlm.nih.gov/pubmed/33521161 http://dx.doi.org/10.36469/jheor.2021.18727

Ejemplares similares

Cost-Effectiveness of Repository Corticotropin Injection versus Standard of Care for the Treatment of Active Rheumatoid Arthritis
por: Bindra, Jas, et al.
Publicado: (2021)

Cost-Effectiveness of Repository Corticotropin Injection for the Treatment of Acute Exacerbations in Multiple Sclerosis
por: Hunter, Samuel F, et al.
Publicado: (2021)

Cost per response analysis of repository corticotropin injection versus other alternative treatments for acute exacerbations of multiple sclerosis
por: Wan, George J, et al.
Publicado: (2020)

Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis
por: Bindra, Jas, et al.
Publicado: (2022)

Safety and Effectiveness of Oral Methylprednisolone Therapy in Comparison With Intramuscular Adrenocorticotropic Hormone and Oral Prednisolone in Children With Infantile Spasms
por: Zhu, Hong-Min, et al.
Publicado: (2021)

Effects of Adrenocorticotropic Hormone Treatment on Heart Muscle in Patients with Infantile Spasm
por: Kutluk, Gültekin, et al.
Publicado: (2020)

Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms
por: Gold, Laura S, et al.
Publicado: (2019)

Long-Term Health Outcomes of Infantile Spasms Following Prednisolone vs. Adrenocorticotropic Hormone Treatment Characterized Using Phenome-Wide Association Study
por: Baker, Monika, et al.
Publicado: (2022)

Treatment of fibrillary glomerulonephritis with use of repository corticotropin injections
por: Maroz, Natallia, et al.
Publicado: (2018)

Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records
por: Chopra, Ishveen, et al.
Publicado: (2019)

Comparison of the Effect of High and Low Doses of Adrenocorticotropic Hormone (ACTH) in the Management of Infantile Spasms
por: FAYYAZI, Afshin, et al.
Publicado: (2020)

Adrenocorticotropic Hormone (ACTH)-Induced Dyskinesias in Infantile Spasms: A Video Case Report
por: Crippa, Ana C.S., et al.
Publicado: (2022)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

EEG biomarkers for the diagnosis and treatment of infantile spasms
por: Romero Milà, Blanca, et al.
Publicado: (2022)

Effectiveness of corticosteroids versus adrenocorticotropic hormone for infantile spasms: a systematic review and meta‐analysis
por: Chang, Yin‐Hsi, et al.
Publicado: (2019)

Hormonal Therapy for Infantile Spasms: A Systematic Review and Meta-Analysis
por: Guang, Shiqi, et al.
Publicado: (2022)

Brain Complexity Predicts Response to Adrenocorticotropic Hormone in Infantile Epileptic Spasms Syndrome: A Retrospective Study
por: Zhang, Chu-Ting, et al.
Publicado: (2022)

Response to magnesium sulfate and adrenocorticotropic hormone combination therapy for infantile spasms with failed first‐line treatments
por: Wang, Qiuhong, et al.
Publicado: (2023)

Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis
por: Busch, Howard, et al.
Publicado: (2022)

A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse
por: Kaplan, Jeffrey, et al.
Publicado: (2020)

The Response of Synthetic Adrenocorticotropic Hormone (ACTH) Treatment in Pediatric Drug-Resistant Epilepsy Other Than Infantile Epileptic Spasms Syndrome: A Retrospective Observational Study
por: Alammar, Hajar, et al.
Publicado: (2023)

Medical resource utilization in dermatomyositis/polymyositis patients treated with repository corticotropin injection, intravenous immunoglobulin, and/or rituximab
por: Knight, Tyler, et al.
Publicado: (2017)

Pain and Fatigue Improvements in Patients Treated with Repository Corticotropin Injection Across Five Indications: A Narrative Review
por: Girman, Cynthia, et al.
Publicado: (2022)

Proteomic Analysis of Adrenocorticotropic Hormone Treatment of an Infantile Spasm Model Induced by N-Methyl-d-Aspartic Acid and Prenatal Stress
por: Wang, Jing, et al.
Publicado: (2012)

Whole genomic approach in mutation discovery of infantile spasms patients
por: Lee, Seungbok, et al.
Publicado: (2022)

Clinical and Economic Evaluation of Repository Corticotropin Injection: A Narrative Literature Review of Treatment Efficacy and Healthcare Resource Utilization for Seven Key Indications
por: Philbin, Michael, et al.
Publicado: (2017)

Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
por: Rice, J. Bradford, et al.
Publicado: (2020)

Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies
por: Patel, Aarat, et al.
Publicado: (2016)

An Epilepsy-Associated Mutation of Salt-Inducible Kinase 1 Increases the Susceptibility to Epileptic Seizures and Interferes with Adrenocorticotropic Hormone Therapy for Infantile Spasms in Mice
por: Pang, Bo, et al.
Publicado: (2022)

De Novo Variants in the DYNC1H1 Gene Associated With Infantile Spasms
por: Yang, Haipo, et al.
Publicado: (2021)

Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection
por: Hayes, Kyle, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Repository Corticotropin Injection Compared With Synthetic ACTH(1‐24) Depot and Methylprednisolone in Healthy Subjects
por: Poola, Nagaraju, et al.
Publicado: (2021)

Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies
por: Fischer, Peter A, et al.
Publicado: (2018)

Treatment of Noninfectious Retinal Vasculitis Using Subcutaneous Repository Corticotropin Injection
por: Anesi, Stephen D., et al.
Publicado: (2021)

Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
por: Mirsaeidi, Mehdi, et al.
Publicado: (2022)

Case report: De novo variant of SETD1A causes infantile epileptic spasms syndrome
por: Lan, Mingping, et al.
Publicado: (2023)

Prediction model for long-term seizure and developmental outcomes among children with infantile epileptic spasms syndrome
por: Arai, Yuto, et al.
Publicado: (2023)

More Hormones, Less Spasms: IGF-1 as a Potential Therapy for Infantile Spasms
por: Dang, Louis T.
Publicado: (2023)

Use of synthetic adrenocorticotropic hormone in patients with IgA nephropathy
por: Prasad, Bhanu, et al.
Publicado: (2018)

Adrenocorticotropic Hormone Therapy Improved Spasms and Sleep Disturbance in Smith–Magenis Syndrome: A Case Report
por: Momosaki, Ken, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t2572j7a49dvbs48vdmk5bqu31